Source comparison
Does MK-677 Help Deep Sleep Optimization?: Comparison
The table below compares MK-677 to other compounds commonly researched or used for sleep optimization, focusing on mechanism, sleep stage effects, and practical considerations. MK-677 (Ibutamoren) Ghrelin receptor agonist → GH secretion Extends SWS (N3) and RE
This comparison does not assign a generated winner or score.
- The table below compares MK-677 to other compounds commonly researched or used for sleep optimization, focusing on mechanism, sleep stage effects, and practical considerations.
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist → GH secretion
- Extends SWS (N3) and REM duration
- 5–7 days of consistent dosing
- Increases appetite significantly; mild water retention
- Best for those seeking restorative deep sleep with metabolic benefits. Appetite stimulation is unavoidable
- Melatonin (3–10mg)
- Circadian regulator (MT1/MT2 agonist)
- Accelerates sleep onset, minimal SWS effect
- Immediate (30–60 min)
- Minimal. Rare grogginess if dosed too high
- Effective for sleep timing issues (jet lag, shift work). Does not deepen sleep architecture
- Glycine (3–5g)
- NMDA receptor co-agonist, GABAergic modulation
- Lowers core body temperature, improves subjective sleep quality
- 1–3 nights
- None. Well-tolerated at research doses
- Gentle option for subjective quality improvements. Lacks the GH-driven restoration MK-677 provides
- Magnesium L-Threonate (140mg elemental)
- NMDA receptor modulation, GABAergic support
- Modest improvements in sleep latency and continuity
- 3–7 days
- Rare GI upset at high doses
- Supports sleep initiation. Weaker evidence for SWS extension compared to MK-677
- Selective GABA-A Agonists (e.g., zolpidem)
- Direct GABA-A receptor activation
- Increases total sleep time but suppresses REM and SWS
- Immediate
- Tolerance, dependence risk, next-day cognitive impairment
- Pharmaceutical sedation. Not restorative sleep optimization
- MK-677 stands apart because it works with your endogenous GH rhythm rather than forcing sedation or merely shifting circadian timing. The appetite stimulation is the primary barrier. Researchers who can't tolerate increased hunger often find glycine or magnesium more practical, even if the sleep architecture benefits are less pronounced.